NASDAQ:IMV IMV (IMV) Stock Price, News & Analysis → New trading system called MSFT, NVDA & MSFT (From WealthPress) (Ad) Free IMV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.49▼$0.9152-Week Range N/AVolume44,800 shsAverage Volume233,607 shsMarket Capitalization$9.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IMV alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About IMV Stock (NASDAQ:IMV)IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry IMV Stock News HeadlinesMay 29 at 9:40 AM | businesswire.comVeristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs TeamMay 27 at 5:17 PM | msn.comUnveiling the New Haval H9: A Benchmark for Future SUVsMay 24, 2024 | msn.com50-year-old man held for reckless driving, damaging cars, bikes in BengaluruMay 22, 2024 | finance.yahoo.comImvax concludes enrolment in Phase IIb glioblastoma treatment trialMay 21, 2024 | finance.yahoo.comImvax Announces Completion of Enrollment in Phase 2b Clinical Trial of IGV-001 and Successful FinancingMay 20, 2024 | msn.comYouth rides bike with girl sitting on fuel tank, arrestedMay 20, 2024 | msn.comMan in Bengaluru booked for riding bike with a woman in his lap. VIDEOMay 15, 2024 | msn.comIMV-IForest: Advanced Conveyor Roller Fault DetectionMay 10, 2024 | ca.finance.yahoo.comBioVaxys Technology Corp. Closes SECOND Tranche of Private PlacementMay 8, 2024 | finanznachrichten.deInflaRx N.V.: InflaRx Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 8, 2024 | msn.comThe Kremlin scores propaganda points with a display of captured tanks and armour ahead of the Victory Day paradeMay 3, 2024 | finance.yahoo.comBioVaxys Technology Corp. Closes First Tranche of Private PlacementMay 2, 2024 | msn.comO.J. Simpson's lawyer ready to meet with Goldman, Brown familiesMay 2, 2024 | msn.comCancer: Monthly horoscope MayApril 30, 2024 | finanznachrichten.deBioVaxys Technology Corp.: Biovaxys Appoints Christopher Cherry As Chief Financial OfficerApril 13, 2024 | msn.comGolden Bachelor news: Gerry and Theresa break up, but still love each otherApril 7, 2024 | msn.comThe Pros And Cons Of Owning Toyota's $13,000 Pickup TruckApril 3, 2024 | msn.comWhy are there so many cars in Omaha without license plates?April 3, 2024 | msn.comVirginia Tech hires Marquette's Megan Duffy as new coachMarch 28, 2024 | finanznachrichten.deCalciMedica, Inc.: CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate UpdatesMarch 27, 2024 | msn.comPhilippines sales up in February 2024March 26, 2024 | msn.comAn Electric Toyota Hilux Is Reportedly Coming by 2025March 26, 2024 | msn.comThe New FJ Cruiser Could Use Toyota's $13,000 Truck PlatformMarch 25, 2024 | theguardian.comAsian hornet may have become established in UK, sighting suggestsMarch 22, 2024 | finanznachrichten.deBioVaxys Technology Corp.: BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENTSee More Headlines Receive IMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2021Today5/30/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMV CUSIPN/A CIK1734768 Webimv-inc.com Phone(902) 492-1819FaxN/AEmployees97Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,990,000.00 Net Margins-11,547.42% Pretax Margin-11,547.42% Return on Equity-12,695.41% Return on Assets-104.84% Debt Debt-to-Equity RatioN/A Current Ratio2.93 Quick Ratio2.93 Sales & Book Value Annual Sales$330,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.69) per share Price / BookN/AMiscellaneous Outstanding Shares11,712,000Free Float11,673,000Market Cap$9.63 million OptionableOptionable Beta0.95 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesAndrew HallChief Executive Office & DirectorJennifer SchmitkeChief Operating OfficerBrittany DavisonChief Accounting Officer, Director & SVP-financeJeremy R. GraffChief Scientific OfficerStéphane FisetVice President-Clinical ResearchKey CompetitorsEyenoviaNASDAQ:EYENVYNE TherapeuticsNASDAQ:VYNEFortress BiotechNASDAQ:FBIOMarker TherapeuticsNASDAQ:MRKRLipocineNASDAQ:LPCNView All Competitors IMV Stock Analysis - Frequently Asked Questions How were IMV's earnings last quarter? IMV Inc. (NASDAQ:IMV) posted its quarterly earnings results on Thursday, November, 11th. The company reported ($1.30) earnings per share for the quarter, hitting analysts' consensus estimates of ($1.30). The firm had revenue of $0.04 million for the quarter. IMV had a negative net margin of 11,547.42% and a negative trailing twelve-month return on equity of 12,695.41%. During the same quarter in the previous year, the firm posted ($1.00) earnings per share. When did IMV's stock split? IMV shares reverse split before market open on Tuesday, December 13th 2022. The 1-10 reverse split was announced on Tuesday, December 13th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. This page (NASDAQ:IMV) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe Exchange[Urgent!] Generational Wealth GameplanCrypto 101 MediaWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMV Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.